xdage Financial Labs
Fund Finance & Private Equity LTV Covenants & DPI Acceleration

NAV Financing & PE Fund Facility Lab

Model institutional Net Asset Value (NAV) fund-level leverage, portfolio company borrowing bases, single-asset concentration caps, LTV covenant tripwires, PIK interest compounding, cash sweep waterfalls, and DPI acceleration vs LP risk.

Fund-Level Leverage

Downstream asset-backed facility pledging underlying portfolio company equity and exit distributions.

Stressed Portfolio NAV

$750.0M

Eligible: $710.0M
Current Drawn LTV

16.0%

Max Limit: 20.0% Initial
Borrowing Base Cap

$142.0M

Undrawn Headroom: $22.0M
Total Annual Carry

$12.6M/yr

All-in Cost: 10.55%
Covenant Health: Compliant / Stable
Cash Sweep: 18.0% LTV Margin Call: 27.5% LTV Default: 35.0% LTV

Underwriting Inputs

-40% Crash 0% Baseline +20% Bull

Deleveraging & LP Waterfall Visualizer

Visualizing multi-year portfolio realization, senior NAV debt repayment sweeps, and residual LP cash distributions.

Actual portfolio LTV trajectory tracked against contractual Cash Sweep (18%), Margin Call (27.5%), and Event of Default (35%) guardrails.

Comparing cumulative cash returned to LPs with NAV facility (immediate liquidity) vs organic asset sales without facility.

5-Year Fund Deleveraging & Distribution Forecast

Timeline Portfolio NAV Debt Balance LTV % Exit Realizations Debt Cash Sweep LP Cash Flow Cumulative LP Cash

LTV Stress Matrix: Valuation Shock vs Drawn Debt

Green ≤ 18% Stable Yellow ≤ 27.5% Sweep Red > 27.5% Cure/Default

Total LP Cash at Yr 5 ($M): Realization Pace vs Margin

Evaluating total LP net cash recoveries factoring in debt service carry costs across exit velocities.

Mathematical Foundations & Underwriting Formulas

1. Eligible Borrowing Base & Concentration Deduction

Senior lenders determine the eligible collateral base by hair-cutting illiquid/Level 3 assets and deducting single-asset concentrations that exceed agreed risk thresholds:

$$\text{Stressed NAV} = \text{NAV}_{\text{Gross}} \times (1 + \text{Shock}) \times (1 - \text{Discount}_{\text{Level3}})$$ $$\text{Eligible Borrowing Base} = \min\left(\text{Facility Limit}, [\text{Stressed NAV} - \text{Excess Concentration}] \times \text{LTV}_{\max}\right)$$

2. LTV Covenants & Equity Cure Remedy

If market downturns drive Loan-to-Value above contractual thresholds, the GP must cure within the remedy period (15–30 days) to prevent loan acceleration:

$$\text{LTV}_t = \frac{\text{Debt Principal}_t}{\text{Stressed NAV}_t}$$ $$\text{Required Equity Cure} = \max\left(0, \text{Debt Principal} - [\text{Stressed NAV} \times \text{LTV}_{\text{Cure}}]\right)$$

Fund Finance Mastery Quiz: NAV Facilities

1. What underlying collateral secures a private equity NAV facility?

2. What distinguishes a Cash Sweep LTV threshold from a Margin Call LTV threshold?

3. Why do private equity sponsors frequently negotiate PIK (Payment-in-Kind) interest margins in NAV loans?

4. What is the fundamental structural risk of a NAV facility for limited partners (LPs)?

Institutional NAV Financing FAQ

A NAV (Net Asset Value) facility is a fund-level asset-backed loan secured by the collective equity value and future cash distributions of a fund's portfolio companies, used during harvesting or mature stages to fund add-on acquisitions or accelerate LP distributions. Unlike subscription lines that rely on uncalled LP commitments, NAV loans look downward into the real market value of underlying investments.

The borrowing base is calculated by taking the eligible portfolio net asset value after deducting unquoted discounts and single-asset concentration limits, then multiplying by the maximum permitted loan-to-value (LTV) advance rate, typically between 15% and 25%. If the fund portfolio has high concentration in a single asset, the excess above the contractual cap (e.g., 20%) is excluded from the borrowing base.

A cash sweep LTV threshold (e.g. 18%) mandates that a percentage of asset sale proceeds be used to pay down senior NAV debt, whereas a margin call LTV (e.g. 27.5%) requires the GP to inject capital or cure the debt balance within a contractual remedy period. Breaching a margin call without curing results in an Event of Default, enabling lenders to seize distribution cash accounts.

GPs utilize NAV facilities during sluggish M&A or IPO exit environments to borrow against unrealized asset value and distribute liquidity to limited partners, boosting Distributed to Paid-In capital (DPI) metrics ahead of new fund fundraising. This provides LPs with interim liquidity, though it encumbers future realization proceeds with senior debt service.

The primary risk for LPs is cross-collateralization and fund-level leverage: NAV loans sit senior to LP equity, meaning that if asset values decline severely, realization proceeds are trapped to pay debt service, subordinating and potentially impairing LP capital recoveries. Additionally, high carry costs and PIK compounding can drag down total fund Net MoIC.

Related Structured Finance & Credit Labs

Subscription Credit Facility Lab

Model uncalled capital commitment borrowing bases, LP credit tiers, exclusion haircuts, and fund IRR elevation.

CLO Waterfall & Coverage Lab

Model leveraged loan securitizations, OC/IC coverage tests, curative cash diversion, and equity tranche IRR cash flows.

Synthetic Risk Transfer Lab

Model bank CRT tranches, Basel III/IV RWA density relief, investor SOFR spreads, and CET1 capital releases.

C-PACE Financing & Green ABS

Model clean energy special tax assessments, non-acceleration covenants, ASHRAE energy SIR ratios, and green bond waterfalls.

Advertisement